柏柏林可以通过细胞和苦味信号来改善硫酸诱导的大肠炎
Yuxuan Yang1, Wenqing Li1, Kaineng Sun1
1Department of Pathogen Biology, Nanjing Medical University, Nanjing, 211166, China.
BMC biology
|December 1, 2024
概括
柏柏林治疗通过调节细胞和苦味信号来缓解炎症性肠病 (IBD). 这项研究揭示了柏柏林在治疗大肠炎中的新机制,为未来的临床使用铺平了道路.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 炎症性肠病 (IBD) 涉及肠道免疫力受损.
- 细胞调节2型免疫反应和肠道屏障修复.
- 柏柏林在临床上用于治疗腹,但其机制尚不清楚.
研究的目的:
- 为了研究柏柏林在硫酸 (DSS) 诱导的大肠炎中的作用.
- 探索贝贝林,细胞和大肠炎之间的关系.
主要方法:
- 在使用DSS的小鼠模型中诱导大肠炎.
- 用柏柏林来评估其治疗效果.
- 使用U73122抑制苦味受体以评估途径参与.
主要成果:
- 柏柏林显著改善了DSS诱导的大肠炎.
- 柏柏林通过细胞调节2型先天性免疫淋巴细胞 (ILC2) 和Th2免疫细胞.
- 抑制苦味受体部分取消了柏柏林的治疗作用.
结论:
- 柏柏林通过细胞和苦味信号来改善DSS诱导的结肠炎.
- 这项研究揭示了贝贝林治疗大肠炎的独特药理机制.
- 这些发现支持柏柏林在治疗IBD方面的进一步临床应用.
相关概念视频
The Physiology of Taste
3.7K
The perception of a salty flavor is facilitated by sodium ions within the oral salivary fluid. Upon consumption of a salty substance, salt crystals disassemble, leading to the liberation of its constituents—Na+ and Cl- ions. These ions subsequently dissolve into the salivary fluid present in the oral cavity. The external environment of the gustatory cells experiences an elevation in Na+ concentration, thereby establishing a potent concentration gradient. This gradient propels the...
3.7K
Drugs for Treatment of Ulcerative Colitis in IBD
119
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
119
Drugs for Treatment of Diarrhea-Predominant IBS
147
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
147


